Internal Medicine Doctors in Spring Lake, NC Accepting Medicare
1 Internal Medicine doctors found. Showing 1 - 1
 Dr. Naveed Khalid Aziz, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 224 N Main St, Spring Lake, NC 28390 Phone: 910-436-0424 Fax: 910-436-0361 |
News Archive
NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced plans to pursue a U.S. label expansion for Qutenza® (capsaicin) 8% patch to include patients with painful HIV-associated neuropathy (HIV-AN, also referred to as HIV-distal sensory polyneuropathy (HIV-DSP)).
HHS adds 1,000 companies to early retiree benefit program
Congress Daily: The federal government added 1,000 companies to the "early retiree benefit program established under the healthcare overhaul law, bringing the total number of companies participating to 3,000. The $5 billion program is a stopgap measure meant to help cover retired Americans over the age of 55 who are not eligible for Medicare."
Individuals with mild Traumatic Brain Injury show brain abnormalities in their white matter
Individuals with mild Traumatic Brain Injury (mTBI), particularly those who have had loss of consciousness (LOC), show structural brain abnormalities in their white matter as measured by Diffusion Tensor Imaging (DTI).
City National Bank donates much-needed items to Valley Presbyterian Hospital's Pediatrics Department
Valley Presbyterian Hospital is excited to announce that City National Bank recently donated much-needed items to the Pediatrics Department. The addition of electronic, gaming and entertainment systems specifically augments recreational activities that the unit's Playroom has to offer to its teenage patient population.
Biocartis closes Series 'B' equity financing round
Biocartis SA, a biotech company active in the field of personalized medicine and focused on fast, multiplexed and fully integrated molecular diagnostics based on its proprietary micro-technology and sample preparation platforms, today announced the successful closing of a Series B equity financing round. The Company raised EUR 30 million (~ USD 41.3 million) from its current shareholder base of leading life science investors and two new strategic investors from the pharmaceutical/diagnostic industry.
› Verified 6 days ago